Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford University and its colleges today announced a major new scholarship scheme for Black graduate students as part of a programme to transform its graduate population by creating more funding opportunities for under-represented groups.

Student in front of the Radcliffe Camera © Ashley Tsai / Graduate Photography Competition

The Black Academic Futures programme will provide up to 10 new scholarships to Black UK research students starting studies next year.

Further graduate funding opportunities for under-represented groups have been launched by the University and colleges, with targeted scholarships for students in the Humanities and the Faculty of Law, and with other measures being taken to widen participation in programmes within the Mathematical, Physical and Life Sciences Division, as well as  Medical Sciences.

Black UK graduate students are particularly under-represented at Oxford (around 1.5% of all postgraduate students compared with 4% across the UK sector). The Black Academic Futures scholarship programme aims to transform this position by rapidly increasing both applications from and funded places for well-qualified UK Black graduate students, reinforcing the University’s commitment to addressing race equality, and combatting discrimination. The new programme builds on the University’s commitment to increasing the number of promising postgraduate students from under-represented groups at Oxford. This includes the UNIQ+ access programme which provides research internships for prospective students from disadvantaged backgrounds, who may find progressing to postgraduate study challenging for reasons other than their academic ability.

Read the full story on the University of Oxford website

Similar stories

Singula Bio, a new Oxford spin-out company - Cancer need not be fatal

General Innovation Research

Singula Bio, a bold new seed-stage biotechnology company spun out of Oxford University, has been launched with the intention of helping show that cancer need not be fatal. Led by three Oxford cancer specialists, the firm is aims to become a world leader in therapies to use against difficult-to-treat solid malignancies such as ovarian cancer - using the body’s own immune system to fight previously fatal cancers.

Major rise in public support for COVID vaccine – Oxford study

Coronavirus COVID-19 General Research

More than three quarters of people in the UK now say they are ’very likely’ to have the vaccine – up from 50% among the same group of survey respondents five months ago –according to a two-wave Oxford University survey published today.

Coronavirus vaccination linked to substantial reduction in hospitalisation, real-world data suggests

Coronavirus COVID-19 General Research

The first study to describe the effects in real-world communities of the Oxford coronavirus vaccine has been reported in a pre-print publication today, showing a clear reduction in the risk of hospitalisation from COVID-19 amongst those who have received the vaccine.

World’s largest clinical trial for COVID-19 treatments expands internationally

Clinical Trials Coronavirus COVID-19 General

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) Trial, the world’s largest clinical trial for COVID-19 treatments, has now expanded internationally with Indonesia and Nepal among the first countries to join. The first patients have been recruited to RECOVERY International.

Reprogramming tumour cells using an antimalarial drug

General Research

Results from the ATOM clinical trial at the University of Oxford have shown that the anti-malarial drug Atovaquone can reduce very low oxygen tumour environments. This has the potential to make cancers behave less aggressively and to improve the impact of everyday cancer treatments.